The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting Drug

Immunology and Allergy Clinics of North America

Volumn 29, Issue 3, 2009, Pages 481-501

  Kano, Yoko ^a   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticonvulsant hypersensitivity syndrome; Drug rash with eosinophilia and systemic symptoms; Drug induced hypersensitivity syndrome; Eosinophilia; Human herpesvirus 6; Liver dysfunction; Skin rash

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOMIPRAMINE; CYANAMIDE; DAPSONE; LAMOTRIGINE; MEXILETINE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE; THIAMAZOLE; TRIBENOSIDE; VALPROIC ACID; ZONISAMIDE;

ACNE VULGARIS; AGRANULOCYTOSIS; ALOPECIA; BIPOLAR DISORDER; CLINICAL FEATURE; COARSE FACE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRESS SYNDROME; DRUG EFFICACY; DRUG ERUPTION; DRUG EXPOSURE; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERITIS; EOSINOPHILIA; ERYTHEMA MULTIFORME; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; FATALITY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GINGIVA HYPERPLASIA; GOUT; HUMAN; HUMAN HERPESVIRUS 6; HYPERURICEMIA; INCIDENCE; INTERSTITIAL NEPHRITIS; KIDNEY DYSFUNCTION; LEPROSY; LEUKOCYTOSIS; LIVER DYSFUNCTION; LUPUS LIKE SYNDROME; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTOSIS; LYMPHOMA; MACULOPAPULAR RASH; PRIORITY JOURNAL; PRURITUS; PUSTULE; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SEIZURE; SERUM SICKNESS; SKIN BIOPSY; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TONIC CLONIC SEIZURE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VIRUS REACTIVATION;

DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EXANTHEMA; HERPESVIRUS 6, HUMAN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RENAL INSUFFICIENCY; ROSEOLOVIRUS INFECTIONS; SEPSIS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 67649195870     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.04.007     Document Type: Review

References (68)

1. Sullivan J.R., and Shear N.H. The drug hypersensitivity syndrome: what is the pathogenesis?. Arch Dermatol 137 3 (2001) 357-364
2. Gennis M.A., Vemuri R., Burns E.A., et al. Familial occurrence of hypersensitivity to phenytoin. Am J Med 91 6 (1991) 631-634
3. Ghislain P.D., and Roujeau J.C. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 8 1 (2002) 5. http://dermatology.cdlib.org/DOJvol8num1/reviews/drugrxn/ghislain.html Available at:
4. Bocquet H., Martine B., and Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 15 4 (1996) 250-257
5. Descamps V., Bouscarat F., Laglenne S., et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 137 4 (1997) 605-608
6. Suzuki Y., Inagi R., Aono T., et al. Human herpesvirus 6 infection as a risk factor of the development of severe drug-induced hypersensitivity. Arch Dermatol 134 9 (1998) 1108-1112
7. Tohyama M., Yahata Y., Yasukawa M., et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134 9 (1998) 1113-1117
8. Hashimoto K., Yasukawa M., and Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 3 4 (2003) 255-260
9. Shiohara T., Iijima M., Ikezawa Z., et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156 5 (2007) 1083-1084
10. Roujeau J.C. Clinical heterogeneity of drug hypersensitivity. Toxicology 209 2 (2005) 123-129
11. Kano Y., Hirahara K., Sakuma K., et al. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 155 2 (2006) 301-306
12. Shiohara T., Takahashi R., and Kano Y. Drug-induced hypersensitivity syndrome and viral reactivation. In: Pichler W.J. (Ed). Drug hypersensitivity (2007), Karger, Basel (Switzerland) 251-266
13. Rijlaarsdam U., Scheffer E., Meijer C.J., et al. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol 24 2 Pt 1 (1991) 216-220
14. Callot V., Roujeau J.C., Bagot M., et al. Drug-induced pseudolymphoma and hypersensitivity syndrome; two different clinical entities. Arch Dermatol 132 11 (1996) 1315-1321
15. Rijlaarsdam J.U., Scheffer E., Meijer C.J., et al. Cutaneous pseudo-T cell lymphomas; a clinicopathologic study of 20 patients. Cancer 69 3 (1992) 717-724
16. Masaki T., Fukunaga A., Tohyama M., et al. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm Venereol 83 2 (2003) 28-31
17. Sekine N., Motokura T., Oki T., et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285 9 (2001) 1153-1154
18. Peyrière H., Dereure O., Breton P., et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol 155 2 (2006) 422-428
19. Kano Y., Inaoka M., and Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 140 2 (2004) 183-188
20. Kano Y., Seishima M., and Shiohara T. Hypogammaglobulinemia as an early sign of drug-induced hypersensitivity syndrome. J Am Acad Dermatol 55 4 (2006) 727-728
21. Boccara O., Valeyrie-Allanore L., Crickx B., et al. Association of hypogammaglobulinemia with DRESS (drug rash with eosinophilia and systemic symptoms). Eur J Dermatol 16 6 (2006) 666-668
22. Wangel A.G., Arvilommi H., and Jokinen I. The effect of phenytoin in vitro on normal human mononuclear cells and on human lymphoblastoid B cell lines of different Ig isotype specificities. Immunobiology 170 3 (1985) 232-238
23. Go T. Carbamazepine-induced IgG1 and IgG2 deficiency associated with B cell maturation defect. Seizure 13 3 (2004) 187-190
24. Shiohara T., and Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 33 1-2 (2007) 124-133
25. Knowles S.R., Shapiro L.E., and Shear N.H. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 21 6 (1999) 489-501
26. Ganeva M., Gancheva T., Lazarova R., et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol 47 8 (2008) 853-860
27. Kansky A., Vodnik A., and Stanovnik L. Serious drug reactions to carbamazepine in oncologic patients after x-ray treatment: report of four cases. Acta Dermatovenerol Alp Panonica Adriat 11 3 (2002) 105-110
28. Shear N.H., and Spielberg S.P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 82 6 (1988) 1826-1832
29. Scheinfeld N. Impact of phenytoin therapy on the skin and skin disease. Expert Opin Drug Saf 3 6 (2004) 655-665
30. Potter T., DiGregorio F., Stiff M., et al. Dilantin hypersensitivity syndrome imitating staphylococcal toxic shock. Arch Dermatol 130 7 (1994) 856-858
31. Conger Jr. L.A., and Grabski W.J. Dilantin hypersensitivity reaction. Cutis 57 4 (1996) 223-226
32. Ting S., Maj M.C., and Dunsky E.H. Diphenylhydantoin-induced hepatitis. Ann Allergy 48 6 (1982) 331-332
33. Sakai C., Takagi T., Oguro M., et al. Erythroderma and marked atypical lymphocytosis mimicking cutaneous T-cell lymphoma probably caused by phenobarbital. Intern Med 32 2 (1993) 182-184
34. Sakuma K., Kano Y., Fukuhara M., et al. Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome. Clin Exp Dermatol 33 3 (2007) 287-290
35. Giordano N., Amendola A., Papakostas P., et al. A clinical case of drug hypersensitivity syndrome with phenobarbital administration: drug-induced rash with eosinophilia and systemic symptoms or lupus-like syndrome?. [letter]. Clin Exp Rheumatol 25 2 (2007) 339
36. Teraki Y., Murota H., and Izaki S. Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6. Arch Dermatol 144 2 (2008) 232-235
37. Iannetti P., Raucci U., Zuccaro P., et al. Lamotrigine hypersensitivity in child hood epilepsy. Epilepsia 39 5 (1998) 502-507
38. Parri N., Bernardini R., Pucci N., et al. Drug rash with eosinophilia and systemic symptoms induced by lamotrigine therapy. Int J Immunopathol Pharmacol 20 3 (2007) 643-645
39. Schaub N., and Bircher A.J. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy 55 2 (2000) 191-193
40. Schlienger R.G., Knowles S.R., and Shear N.H. Lamotrigine-associated anticonvulsant hypersensitivity syndrome. Neurology 51 4 (1998) 1172-1175
41. Elasy T., Kaminsky D., Tracy M., et al. Allopurinol hypersensitivity syndrome revisited. West J Med 162 4 (1995) 360-361
42. Emmerson B.T. The management of gout. N Engl J Med 334 7 (1996) 445-451
43. Kumar A., Edward N., White M.I., et al. Allopurinol, erythema multiforme, and renal insufficiency. BMJ 312 7024 (1996) 173-174
44. *5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 102 11 (2005) 4134-4139
45. Kano Y., Hirahara K., Asano Y., et al. HLA-B allele association with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm Venereol 88 6 (2008) 616-618
46. Arakawa M., Kakuto Y., Ichikawa K., et al. Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia. Intern Med 40 4 (2001) 331-335
47. Sommers L.M., and Schoene R.B. Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus. Arch Intern Med 162 10 (2002) 1190-1192
48. Colvin J.H., and Sheth A.P. Minocycline hypersensitivity syndrome with hypotension mimicking septic shock. Pediatr Dermatol 18 4 (2001) 295-298
49. Knowles S.R., Shapiro L., and Shear N.H. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Arch Dermatol 132 8 (1996) 934-939
50. Roca B., Calvo B., and Ferrer D. Minocycline hypersensitivity reaction with acute respiratory distress syndrome. Intensive Care Med 29 2 (2003) 338
51. Gough A., Chapman S., Wagstaff K., et al. Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 312 7024 (1996) 169-172
52. Leslie K.S., Gaffney K., Ross C.N., et al. A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. Clin Exp Dermatol 28 5 (2003) 496-498
53. Sener O., Doganci L., Safali M., et al. Severe dapsone hypersensitivity syndrome. J Investig Allergol Clin Immunol 16 4 (2006) 268-270
54. Itha S., Kumar A., Dhingra S., et al. Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gastroenterol 3 (2003) 21. http://www.biomedcentral.com/1471-230X/3/21 Available at: http://www.biomedcentral.com/1471-230X/3/21.
55. Agrawal S., and Agarwalla A. Dapsone hypersensitivity syndrome: a clinico-epidemiological review. J Dermatol 32 11 (2005) 883-889
56. Teo R.Y., Tay Y.K., Tan C.H., et al. Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis. Ann Acad Med Singap 35 11 (2006) 833-836
57. Takahashi H., Tanaka M., Tanikawa A., et al. A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus. Clin Exp Dermatol 31 1 (2006) 33-35
58. Kunisaki Y., Goto H., Kitagawa K., et al. Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of human herpesvirus 6. Intern Med 42 2 (2003) 203-207
59. Descloux E., Argaud L., Dumortier J., et al. Favourable issue of a fulminant hepatitis associated with sulfasalazine DRESS syndrome without liver transplantation. Intensive Care Med 31 12 (2005) 1727-1728
60. Higa K., Hirata K., and Dan K. Mexiletine-induced severe skin eruption, fever, eosinophilia, lymphocytosis, and liver dysfunction. Pain 73 1 (1997) 97-99
61. Sekiguchi A., Kashiwagi T., Ishida-Yamamoto A., et al. Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpesvirus 6 and cytomegalovirus reactivation. J Dermatol 32 4 (2005) 278-281
62. Yagami A., Yoshikawa T., Asano Y., et al. Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7. Dermatology 213 4 (2006) 341-344
63. Sasaki K., Yamamoto T., Kishi M., et al. Acute exanthematous pustular drug eruption induced by mexiletine. Eur J Dermatol 11 5 (2001) 469-471
64. Seino Y., Yamauchi M., Hirai C., et al. A case of fulminant Type 1 diabetes associated with mexiletine hypersensitivity syndrome. Diabet Med 21 10 (2004) 1156-1157
65. Mitani N., Aihara M., Yamakawa Y., et al. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol 75 3 (2005) 430-434
66. Hashizume H., and Takigawa M. Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Derm Venereol 85 1 (2005) 47-50
67. Ozaki N., Miura Y., Sakakibara A., et al. A case of hypersensitivity syndrome induced by methimazole for Graves' disease. Thyroid 15 12 (2005) 1333-1336
68. Nishimura Y., Kitoh A., Yoshida Y., et al. Clomipramine-induced hypersensitivity syndrome with unusual clinical features. J Am Acad Dermatol 53 Suppl 1 (2005) S231-S233